Novel percutaneous cardiac assist devices: The science of and indications for hemodynamic support

Circulation

Volumn 123, Issue 5, 2011, Pages 533-543

  Naidu, Srihari S ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CARDIOGENIC SHOCK; CIRCULATION; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TAMPONADE; HUMAN; LIMB ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE;

HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MYOCARDIAL INFARCTION;

EID: 79951613729     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.945055     Document Type: Review

References (72)

1. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV Jr, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1996 - 2006. Am Heart J. 2008;156:1019-1022.
2. Goldberg RJ, Spencer Fa, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patient with acute myo-cardial infarction: a population-based perspective. Circulation. 2009;119: 1211-1219.
3. Fang J, Alderman MH, Keenan NL, Ayala C. Acute myocardial infarction hospitalization in the United States, 1979 to 2005. Am J Med. 2010;123: 259-266.
4. Floyd KC, Yarzebski J, Spencer FA, Lessard D, Dalen JE, Alpert JS, Gore JM, Goldberg RJ. A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009;2:88-95.
5. Torabi A, Rigby AS, Cleland JG. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol. 2009;55:79-81.
6. Liu L. Changes in cardiovascular hospitalization and comorbidity of heart failure in the United States: findings from the National Hospital Discharge Surveys 1980 -2006. Int J Cardiol. 2010 Jan 6. [epub ahead of print].
7. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998;66:1632-1639. (Pubitemid 29030164)
8. Rossi JS, Flaherty JD, Fonarow GC, Nunez E, Gattis Stough W, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, Yancy CW, Young JB, Davidson CJ, Gheorghiade M. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF. Eur J Heart Fail. 2008;10:1215-1223.
9. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003; 289:2685-2694. (Pubitemid 37430139)
10. Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, McDonagh TA, Cowie MR. Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart. 2009;95:1851-1856.
11. Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the NHLBI-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Interv. 2009;2:6-13.
12. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the ACC-NCDR. Catheter Cardiovasc Interv. 2006;68:867-872. (Pubitemid 44847091)
13. Jensen LO, Kaltoft A, Thayssen P, Tilsted HH, Christiansen EH, Mikkelsen KV, Maeng M, Hansen KN, Volladsen AB, Madsen M, Lassen JF, Pedersen KE, Thuesen L. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75:101-108.
14. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH; SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341: 625-634. (Pubitemid 29399041)
15. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier HD, Ocampo HA. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest. 1989; 96:120-126. (Pubitemid 19176427)
16. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547. (Pubitemid 34269999)
17. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decom-pensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57-64. (Pubitemid 40905130)
18. Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009; 24:293-316.
19. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catechol-amine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol. 2004;89:407-416. (Pubitemid 39023182)
20. Culling W, Penny WJ. Arrhythmogenic and electrophysiological effects of alpha adrenoreceptor stimulation during myocardial ischemia and reperfusion. J Mol Cell Cardiol. 1987;19:251-258. (Pubitemid 17064575)
21. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113-118.
22. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a co-operative clinical trial. N Engl J Med. 1973;288:979-984.
23. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459-468.
24. Weber KT, Janicki JS. Intraaortic balloon counterpulsation: a review of physiological principles, clinical results and device safety. Ann Thorac Surg. 1974;17:602-636.
25. Buckley MJ, Leinbach RC, Kastor JA, Laird JD, Kantrowitz AR, MJadras PN, Sanders CA, Austen WG. Hemodynamic evaluation of intra-aortic balloon pumping in man. Circulation. 1970;41(suppl):130-136.
26. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36(suppl):S106-S111.
27. Connors AF Jr, Speroff T, Drawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ Jr, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA; SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-897. (Pubitemid 26301608)
28. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: ESCAPE trial. JAMA. 2005;294:1625-1633. (Pubitemid 41407355)
29. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44: 340-348. (Pubitemid 38950593)
30. Torgerson C, Schmittinger CA, Wagner S, Ulmer H, Takala J, Jakob SM, Dunser MW. Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Critical Care. 2009;13:R157.
31. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J. 2007;153:366-370. (Pubitemid 46328753)
32. Braunwald E. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout. J Am Coll Cardiol. 1999;34: 1365-1368.
33. Ardehali A, Ports TA. Myocardial oxygen supply and demand. Chest. 1990;98:699-705. (Pubitemid 20352706)
34. Krams R, Sipkema P, Westerhof N. Varying elastance concept may explain coronary systolic flow impediment. Am J Physiol. 1989;257: H1471-H1479.
35. Claessen BE, Bax M, Delewi R, Meuwissen M, Henriques JP, Piek JJ. The Doppler flow wire in acute myocardial infarction. Heart. 2010;96: 631-635.
36. Chatterjee K. Coronary hemodynamics in heart failure and effects of therapeutic interventions. J Cardiac Fail. 2009;15:116-123.
37. Rodbard S, Williams CB, Rodbard D, Berglund E. Myocardial tension and oxygen uptake. Circ Res. 1964;14:139-149.
38. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol. 2005;289:H501-H512. (Pubitemid 41129360)
39. Suga H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol. 1979;236:H498-H505.
40. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Hata K, Mori M, Yokoyama M. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation. 1993;87:59-69. (Pubitemid 23019334)
41. Schipke JD, Burkhoff D, Kass DA, Alexander J Jr, Schaefer J, Sagawa K. Hemodynamic dependence of myocardial oxygen consumption indices. Am J Physiol. 1990;258:H1281-H1291. (Pubitemid 20187192)
42. Remmelink M. Sjauw KD, Henriques JP, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BA, Tijssen JG, Piek JJ, Baan J Jr. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75:187-194.
43. Vranckx P, Foley DP, de Feijter PJ, Vos J, Smits P, Serruys PW. Clinical introduction of the Tandem Heart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent. 2003;5:35-39. (Pubitemid 36227313)
44. Thiele H, Lauer B, Hambrecht R, Boudreit E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104:2917-2922. (Pubitemid 33139103)
45. Al-Husami W, Yturralde F, Mohanty G, Pastore C, Lotrun K, Venesy D, Waxman S, Pyne C, Gossman D, Nesto R, Piemonte T. Single-center experience with the Tandem Heart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2008;20:319-322. (Pubitemid 351940888)
46. Burkhoff D, Tyberg JV. Why does pulmonary venous pressure rise following the onset of left ventricular dysfunction: a theoretical analysis. Am J Physiol. 1993;265:H1819-H1828. (Pubitemid 23348219)
47. Santamore WP, Burkhoff D. Hemodynamic consequences of ventricular interaction as assessed by model analysis. Am J Physiol. 1991;260: H146-H157.
48. Dickstein ML, Burkhoff D. A theoretical analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant. 1996;15:715-721. (Pubitemid 26268891)
49. Dickstein ML, Spotnitz HM, Rose EA, Burkhoff D. Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Car-diovasc Surg. 1997;113:1032-1040. (Pubitemid 27271107)
50. Artrip JH, Oz M, Burkhoff D. Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J Thorac Cardiovasc Surg. 2001;122:775-782.
51. Hay I, Rich J, Ferber P, Burkhoff D, Maurer MS. Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol. 2005;288:H1203-H1208. (Pubitemid 40270025)
52. Sweeney MS. The Hemopump in 1997: a clinical, political and marketing evolution. Ann Thorac Surg. 1999;68:761-763. (Pubitemid 29521164)
53. Morley D, Litwak K, Ferber P, Spence P, Dowling R, Meyns B, Griffith B, Burkhoff D. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg. 2007;133:21-28.
54. Burkhoff D, Wechsler AS. Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J Thorac Cardiovasc Surg. 2006; 132:459-463. (Pubitemid 44278919)
55. Fonger JD, Zhou Y, Matsuura H, Aldea GS, Shemin RJ. Enhanced preservation of acutely ischemic myocardium with trans-septal left ventricular assist. Ann Thorac Surg. 1994;57:570-575. (Pubitemid 24114947)
56. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascu-larized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-1283. (Pubitemid 41435457)
57. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; Tandem Heart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the Tandem Heart percutaneous ventricular assist device versus conventional therapy with intra-aortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152: 469.e1-e8.
58. Sjauw KD, Engstrom AE, Henriques JP. Percutaneous mechanical cardiac assist in myocardial infarction: where are we now, where are we going? Acute Card Care. 2007;9:222-230. (Pubitemid 350145788)
59. Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, Myers TJ, Gregoric ID, Delgado RM. Clinical experience with the Tandem Heart percutaneous ventricular assist device. Tex Heart Inst J. 2006;33:111-115. (Pubitemid 44299837)
60. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW. The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions: the six-year Rotterdam experience. Eurointervention. 2008;4:331-337.
61. Thomas JL, Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, Burstein S, Shavelle DM. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. J Invasive Cardiol. 2010;22:360-364.
62. Sjauw KD, Remmelink M, Baan J, Lam K, Engstrom AE, van der Schaaf RJ, Vis MM, Koch KT, van Straalen JP, Tijssen JG, de Mol BA, de Winter RJ, Piek JJ, Henriques JP. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51:1044-1046. (Pubitemid 351318126)
63. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT 1 Trial): initial US experience. J Am Coll Cardiol Cardiovasc Interv. 2009;2:91-96.
64. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Jr. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynam-ics. Catheter Cardiovasc Interv. 2007;70:532-537. (Pubitemid 47597025)
65. Raess DH, Weber DM. Impella 25. J Cardiovasc Trans Res. 2009;2: 168-172.
66. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65:263-267. (Pubitemid 40791523)
67. Sauren LD, Accord RE, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, Maessen JG. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs. 2007;31: 839-842. (Pubitemid 350131996)
68. Henriques JP, Remmelink M, Baan J, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97:990-992.
69. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52: 1584-1588.
70. Maini B. USpella registry. In: Transcatheter Cardiovascular Therapeutics (TCT) Scientific Sessions. San Francisco, CA; September 2009. Abstract.
71. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrom T, Hassager C, Machado FP, Peddrazini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JP. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: the Europella registry. J Am Coll Cardiol. 2009;54:2430-2434.
72. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304:867-874.